Blood Test Can Detect Cancer Risk 10 Years Early, Study Finds

A new medical study has revealed that a blood test could detect the risk of head and neck cancer up to 10 years in advance, offering a major breakthrough in early diagnosis and prevention.

According to data from the United States, nearly 70% of head and neck cancers are linked to the Human Papillomavirus (HPV). Unlike cervical cancer, there have been limited early detection methods for these cancers, often leading to diagnosis only after tumors have significantly developed.

Researchers have now developed a novel liquid biopsy tool combined with HPV-DeepSeek technology, which can identify microscopic fragments of HPV DNA released into the bloodstream by cancer cells. This method uses whole-genome sequencing and is reported to be more effective than existing diagnostic techniques.

In the study, scientists tested 56 blood samples and identified early cancer risk in 28 individuals, enabling preventive treatment. Among them, 22 showed detectable tumor DNA fragments, highlighting the test’s strong potential for early detection.

Experts say that undergoing such advanced screening methods could help individuals detect and prevent head and neck cancers at an early stage, significantly improving treatment outcomes and survival rates.